Active Grants

Below is a list of the “active” grants of the Flinn Foundation—those grants that have been awarded and have yet to receive final payment; and/or for which grant-related activities have not concluded.

Many Flinn Foundation grants are multiple-year awards that receive payments throughout the duration of the grant. In some cases, grants are extended (without additional funding provided) beyond their scheduled date of conclusion.

This list is not comprehensive, as it excludes grants for membership dues to philanthropic organizations and other miscellaneous awards, but represents the Foundation’s project-specific grant-making activity to achieve its strategic goals.

Translational Genomics Research Institute (TGen)

City: Phoenix

Amount: $200,000

Award Date: 2019

Duration: 12 months

Program Area: Bioscience

Block funding to the Translational Genomics Research Institute help high-caliber researchers, selected by the institution, increase their competitiveness for large multi-year National Institute of Health (NIH) awards that are a critical source of funding for their long-term success and that of their institutions. This grant is awarded under the Flinn Foundation Bridge-Funding Initiative to increase Arizona’s share of NIH funding.

University of Arizona

City: Tucson

Amount: $288,000

Award Date: 2021

Duration: 36 months

Program Area: Bioscience

Support for a project to investigate neurotoxic effects associated with exposure to contaminants on lands of the Cocopah Indian Tribe in southwestern Arizona. The project will leverage previous research in the Yuma area undertaken with Flinn Foundation support.

University of Arizona

City: Tucson

Amount: $162,000

Award Date: 2021

Duration: 48 months

Program Area: Flinn Scholars

Scholarship awards for the Flinn Scholars Class of 2021.

University of Arizona

City: Tucson

Amount: $100,000

Award Date: 2021

Duration: 18 months

Program Area: Bioscience

Support for a project, in partnership with Banner University Medical Center – Tucson, to establish a novel treatment for the deadly bacterial pathogen C. difficile. C. difficile infections, or CDI, are the most common healthcare-associated infection in many hospitals and there are currently no preventive treatments or vaccines for the disease. The researchers will further study their non-antibiotic, orally palatable therapeutic, Syn-LAB, with the hope of moving the treatment into clinical development. This grant is awarded under the Flinn Foundation Translational Research Seed Grant Initiative to support research collaborations between basic scientists and clinical researchers.

University of Arizona

City: Tucson

Amount: $100,000

Award Date: 2021

Duration: 18 months

Program Area: Bioscience

Support for a project to develop a blood test that can diagnose chronic lung diseases at the onset of symptoms that is less invasive and costly. Today, it often takes between two and four years to make a correct diagnosis of the often-fatal lung diseases because of the non-specific symptoms. The new blood test would allow patients to learn their diagnosis within days and start therapeutic intervention when the responsiveness to treatment is still high. This grant is awarded under the Flinn Foundation Translational Research Seed Grant Initiative to support research collaborations between basic scientists and clinical researchers.